Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation

- Recurrent irregular heartbeat--also known as atrial fibrillation--impacts more than 16 million people globally
Source: Abbott.com - Category: Pharmaceuticals Source Type: news